Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort.

Actas dermo-sifiliograficas·2025

Same author

[Translated article] Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP Registry.

Actas dermo-sifiliograficas·2025

Same author

Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP Registry.

Actas dermo-sifiliograficas·2024

Same author

[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Actas dermo-sifiliograficas·2023

Same author

BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Actas dermo-sifiliograficas·2023

Same author

Treatment Persistence and Safety of Apremilast in Psoriasis: Experience With 30 Patients in Routine Clinical Practice.

Actas dermo-sifiliograficas·2020

Same journal

Fingolimod-associated lymphomatoid papulosis.

Actas dermo-sifiliograficas·2026

Same journal

Demodicosis: update and treatment with laser and other light sources.

Actas dermo-sifiliograficas·2026

Same journal

New treatments for adult female acne.

Actas dermo-sifiliograficas·2026

Same journal

First regulations of the Spanish Society of Dermatology (1909).

Actas dermo-sifiliograficas·2026

Same journal

Long-hair FUE: advantages and disadvantages of the most recent technique in hair transplantation.

Actas dermo-sifiliograficas·2026

Same journal

Sunburns, Tanning, and Social Media: A Descriptive Study Among Spanish University Students.

Actas dermo-sifiliograficas·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Mucosal melanoma: an update.

R Ballester Sánchez¹, B de Unamuno Bustos¹, M Navarro Mira¹

¹Servicio de Dermatología, Hospital Universitario y Politécnico La Fe, Valencia, España.

Actas Dermo-Sifiliograficas

|July 22, 2014

Summary

This summary is machine-generated.

Mucosal melanoma, a rare cancer, is often diagnosed late. Targeted therapies like imatinib show promise for metastatic cases due to common c-KIT mutations.

Keywords:

Anorectal melanoma Head and neck melanoma Imatinib Melanoma ano-rectal Melanoma de cabeza y cuello Melanoma mucoso Melanoma vulvo-vaginal Mucosal melanoma Vulvovaginal melanoma c-KIT

More Related Videos

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Experiment Videos

Last Updated: Apr 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Area of Science:

Oncology
Dermatology
Pathology

Background:

Mucosal melanoma is a rare subtype distinct from cutaneous melanoma in biology and presentation.
Late diagnosis is common due to non-specific signs and difficult lesion accessibility.
Current management strategies for localized disease include surgical excision, with adjuvant radiotherapy for local control.

Purpose of the Study:

To summarize the unique characteristics, diagnostic challenges, and treatment modalities for mucosal melanoma.
To highlight the role of specific genetic mutations in guiding therapeutic decisions for advanced disease.

Main Methods:

Review of existing literature on mucosal melanoma.
Analysis of clinical manifestations, diagnostic approaches, and treatment outcomes.
Focus on the implications of c-KIT mutations in therapeutic advancements.

Main Results:

Mucosal melanoma presents unique biological and clinical features compared to cutaneous melanoma.
Delayed diagnosis is a significant challenge.
Surgical excision is standard for localized disease; radiotherapy has a role in local control.
c-KIT mutations are more prevalent, informing the use of imatinib in metastatic settings.

Conclusions:

Mucosal melanoma requires distinct diagnostic and management strategies.
Targeted therapy, particularly imatinib for c-KIT mutated cases, offers new hope for metastatic disease.